Table 2.
Quality assessment of the included studies
| Selection | Comparability | Outcome measurement | Total score | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Patient definition | Representat-iveness of patients | Selection of controls | Definition of controls | Age | Gender/ education | Ascertainment of outcome | Same method of ascertainment for case and control | Non-response rate | ||
| Graae et al. (1996) [55] | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 7 |
| Arikan et al. (2019) [56] | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 4 |
| Benschop et al. (2019) [57] | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 6 |
| Roh et al. (2020) [58] | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 5 |
| Iznak et al. (2021) [59] | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 7 |
| Krepel et al. (2021) [60] | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 7 |
| Amico et al. (2023) [61] | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 4 |
| Bankwitz et al. (2023) [62] | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 7 |
| Jiang et la. (2023) [63] | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 7 |
| Ozger et al. (2023) [64] | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 4 |
| He et al. (2024) [65] | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 4 |